Testing for Biotin Interference in In Vitro Diagnostic Devices: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 16, 2020
June 11, 2021
1a6a74f2-3b19-490b-9847-11a56bd093bf
Related Documents
Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products: Guidance for Industry
Guidance DocumentDecember 16, 2020Center for Biologics Evaluation and Research
Evaluation of Devices Used with Regenerative Medicine Advanced Therapies: Guidance for Industry
Guidance DocumentFebruary 15, 2019Center for Biologics Evaluation and Research
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentJuly 20, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox